Zobrazeno 1 - 10
of 89
pro vyhledávání: '"G Y, Minuk"'
Publikováno v:
Digestive diseases and sciences. 65(1)
The high prevalence of nonalcoholic fatty liver disease (NAFLD) in the general population warrants determining whether pocket-sized ultrasound devices (PoCUS) might serve as point-of-care screening for NAFLD in busy office practices. One hundred adul
Publikováno v:
Molecular biology reports. 45(5)
Docosahexaenoic acid (DHA) is an omega-3 polyunsaturated fatty acid with anti-cancer properties. Recently, DHA packaged within low-density lipoprotein (LDL) nanoparticles (LDL–DHA) was demonstrated to be effective in a murine model of hepatocellula
Publikováno v:
Gastroenterology, Hepatology and Endoscopy. 1
Autor:
Kelly Kaita, Eberhard L. Renner, G. Y. Minuk, Stephen Wong, L. Minuk, K. Hawkins, Julia Uhanova
Publikováno v:
Digestive Diseases and Sciences. 56:1235-1241
Progressive deterioration in liver function is a common cause of hepatic decompensation and indication for liver transplantation in patients with advanced liver disease. Previous studies in animal models of acute and chronic liver disease revealed th
Publikováno v:
Liver. 6:199-204
Bacterial endotoxins are known to be an important cause of cholestasis, yet not all organisms that cause cholestasis produce endotoxins. In order to determine whether bacterial products other than endotoxins may be involved in the cholestasis process
Publikováno v:
Liver. 17:13-16
The ability to document nuclear proliferation in the liver is essential to our understanding of hepatic regeneration and hepatocellular carcinoma. While numerous tests are available to provide such information in experimental animals, few can be appl
Autor:
G. Y. Minuk, S. S. Lee, E. Lentz, Mitchell L. Shiffman, Sugantha Govindarajan, Paul J. Pockros, Robert Reindollar, Luis A. Balart, E. J. Heathcote, Gregory T. Everson
Publikováno v:
Alimentary Pharmacology & Therapeutics. 27:542-551
Summary Background Patients with chronic hepatitis C virus and advanced fibrosis or cirrhosis are at risk for disease progression and hepatic decompensation. Aim To determine the effects on hepatic histology of treatment with peginterferon alfa-2a (9
Autor:
S Liu, Julia Uhanova, G. Y. Minuk, Julia D. Rempel, Stephen Wong, Kelly Kaita, Eberhard L. Renner
Publikováno v:
Canadian Journal of Gastroenterology, Vol 22, Iss 10, Pp 829-834 (2008)
North American Aboriginal populations are at increased risk for developing immune-mediated disorders, including autoimmune hepatitis. In the present study, the demographic, clinical, biochemical, serological, radiological and histological features of
Publikováno v:
Digestive Diseases and Sciences. 51:1179-1182
The intact liver exists in a state of replicative quiescence. The factor(s) responsible for maintaining this state and their tissue sources have yet to be identified. Because the colon synthesizes and/or absorbs numerous agents that inhibit hepatocyt
Publikováno v:
Gut. 52:1046-1053
Background: Hepatic adenosine triphosphate (ATP) levels are an accurate reflection of functioning hepatic mass following surgical resections and acute liver injury. Objective: To determine whether hepatic ATP levels can serve as a non-invasive means